{"id":"NCT02034162","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants","officialTitle":"A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of a 500-mg Chewable Tablet of Mebendazole in the Treatment of Soil-Transmitted Helminth Infections (Ascaris Lumbricoides and Trichuris Trichiura) in Pediatric Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2015-09","completion":"2015-09","firstPosted":"2014-01-13","resultsPosted":"2016-11-04","lastUpdate":"2016-11-04"},"enrollment":295,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Helminth Infections"],"interventions":[{"type":"DRUG","name":"Mebendazole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Mebendazole","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of mebendazole compared with placebo in pediatric participants with Helminth infections.","primaryOutcome":{"measure":"Cure Rate for Ascaris Lumbricoides at the End of Double-blind Treatment Period","timeFrame":"At Visit 3 (Day 19) of Double-blind treatment period","effectByArm":[{"arm":"Double-blind Placebo","deltaMin":11.1,"sd":null},{"arm":"Double-blind Mebendazole 500 mg","deltaMin":83.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":3,"countries":["Ethiopia","Rwanda"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":140},"commonTop":["Abdominal Distension","Abdominal Pain","Nasopharyngitis","Cough","Diarrhoea"]}}